GSK3528869A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3528869A, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection [Phase 1, Phase 2]